Results 191 to 200 of about 23,592 (245)
Cancer nanovaccines have emerged as promising alternatives to conventional cancer vaccines, which have shown limited clinical efficacy. In particular, cell membrane nanoparticle‐based nanovaccines can offer high biocompatibility and immunogenicity while preserving tumor antigens, including antigen repertoires.
Munsik Kim, Ilkoo Noh
wiley +1 more source
The Potential of Apelin-Targeted Therapeutic Lymphangiogenesis Therapy for Viral Myocarditis. [PDF]
Shimizu Y.
europepmc +1 more source
ABSTRACT Targeting iron‐dependent ferroptosis with siRNA has emerged as a promising strategy for cancer treatment. The concept of ferrous‐supply regeneration, inspired by electro‐Fenton technology, has also gained interest as a non‐apoptotic approach to induce ferroptosis.
Dun Hu +6 more
wiley +1 more source
Thermo‐responsive granular hydrogels (TRGHs), composed of microparticles and an interstitial matrix, exhibit thermo‐responsive mechanical properties and allow cell infiltration. This system effectively addresses the conventional compromise between mechanical strength and porosity observed in granular hydrogels.
Jun Kim, Soyeon Kwon, Taimoor H. Qazi
wiley +1 more source
Macrocystic Lymphangioma of the Chest Wall: A Rare Localization. [PDF]
Benradi L, Belahcen M.
europepmc +1 more source
Density of Blood and Lymphatic Vessels in Stretch Marks: A Preliminary Study. [PDF]
Piotrowska A +6 more
europepmc +1 more source
Pedunculated Polypoidal Anal Canal Lymphangioma in an Adult Male: A Report of a Rare Case and Review of the Literature. [PDF]
Thiagarajan K +3 more
europepmc +1 more source
The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions. [PDF]
Li C, Xu B, Liu R.
europepmc +1 more source
Novel Combination Therapy with Sorafenib and Propranolol for Refractory Lymphangioma Circumscriptum. [PDF]
Roy A, Rajput G, Sridhar J, Patel A.
europepmc +1 more source

